Evidence map›Paper›PMID 31367240›Full record

ArticleTheranostics2019

A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice.

Endika Prieto-Fernández, Ana María Aransay, Félix Royo, Esperanza González, Juan José Lozano, Borja Santos-Zorrozua, Nuria Macias-Camara, Monika González, Raquel Pérez Garay, Javier Benito and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. The Landscape of Exosomes Biogenesis to Clinical Applications.International journal of nanomedicine · 2024
    Review
  7. Review
  8. Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing.International journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Endika Prieto-FernándezDepartment of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of The Basque Country (UPV/EHU), Leioa, Bizkaia, 48940, Spain.
Ana María AransayGenome Analysis Platform, CIC bioGUNE, Derio, Bizkaia, 48980, Spain.
Félix RoyoExosomes Lab, CIC bioGUNE, CIBERehd, Derio, Bizkaia, 48980, Spain.
Esperanza GonzálezExosomes Lab, CIC bioGUNE, CIBERehd, Derio, Bizkaia, 48980, Spain.
Juan José LozanoBioinformatics Unit, Centre Esther Koplovitz (CEK), CIBERehd, Barcelona, 08036, Spain.
Borja Santos-ZorrozuaDepartment of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of The Basque Country (UPV/EHU), Leioa, Bizkaia, 48940, Spain.
Nuria Macias-CamaraGenome Analysis Platform, CIC bioGUNE, Derio, Bizkaia, 48980, Spain.
Monika GonzálezGenome Analysis Platform, CIC bioGUNE, Derio, Bizkaia, 48980, Spain.
Raquel Pérez GarayBiochemistry Service, Cruces University Hospital, Barakaldo, Bizkaia, 48903, Spain.
Javier BenitoDepartment of Pediatric Emergency, Cruces University Hospital, Barakaldo, Bizkaia, 48903, Spain.
Africa Garcia-OradDepartment of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of The Basque Country (UPV/EHU), Leioa, Bizkaia, 48940, Spain.
Juan Manuel Falcón-PérezCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, 28029, Spain.
CIC bioGUNE · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESBioCruces Health research Institute · ESHospital de Cruces · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebrospinal fluid (CSF) microRNAs (miRNAs) have emerged as potential biomarkers for minimally invasive diagnosis of central nervous system malignancies. However, despite significant advances in recent years, this field still suffers from poor data reproducibility. This is especially true in cases of infants, considered a new subject group. Implementing efficient methods to study miRNAs from clinically realistic CSF volumes is necessary for the identification of new biomarkers.

Indexed as

Central Nervous System NeoplasmsExosomesExtracellular VesiclesHumansInfantInfant, NewbornMicroRNAsReal-Time Polymerase Chain ReactionReproducibility of ResultsSequence Analysis, RNAMicroRNAsclinical samplesCSF exosomesCSF miRNAsinfantsmicroRNA profiling

Identifiers

PMID31367240
PMCPMC6643433
OpenAlexW2959758719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.